Tengion Newswire

Comprehensive Real-Time News Feed for Tengion.

Results 1 - 10 of 10 in Tengion

  1. Regenerative medicine company with local ties files for bankruptcyRead the original story w/Photo

    Tuesday Dec 30 | Business Journal

    Tengion Inc., a North Carolina regenerative medicine company that was once based in Montgomery County, Pa., has filed for bankruptcy. Tengion was founded in founded in 2003 to commercialize organ-regenerating technology developed in the laboratory of Dr. Anthony Atala at Wake Forest University's Institute for Regenerative Medicine.

    Comment?

  2. Regenerative medicine company with local ties files for bankruptcyRead the original story w/Photo

    Tuesday Dec 30 | Business Journal

    Tengion Inc., a North Carolina regenerative medicine company that was once based in Montgomery County, Pa., has filed for bankruptcy. Tengion was founded in founded in 2003 to commercialize organ-regenerating technology developed in the laboratory of Dr. Anthony Atala at Wake Forest University's Institute for Regenerative Medicine.

    Comment?

  3. Tengion came back from the brink multiple times before sliding into bankruptcyRead the original story w/Photo

    Tuesday Dec 30 | Business Journal

    Tengion arrived in Winston-Salem in the summer of 2004, brought here by its connection to renowned scientist Dr. Anthony Atala , who now heads the Wake Forest Institute of Regenerative Medicine. But after a decade of trying to successfully commercialize Atala's discoveries in tissue regeneration, with a specific focus on bladder and kidney research, the biotech firm filed for Chapter 7 bankruptcy after terminating most of its executive team.

    Comment?

  4. Struggling Tengion Inc. Files for Chapter 7 Bankruptcy ProtectionRead the original story

    Monday Dec 29 | BioSpace

    Tengion Inc., a Winston-Salem-based firm that's been developing regenerative medicine technologies, is seeking bankruptcy protection. The company has begun a Chapter 7 case in U.S. Bankruptcy Court for the District of Delaware, according to a filing it made on Monday with the U.S. Securities and Exchange Commission.

    Comment?

  5. Triad biotech firm seeks bankruptcy protectionRead the original story w/Photo

    Tuesday Dec 30 | Business Journal

    A Tengion lab technician loads centrifuge to collect bladder cells from tissue. The company is seeking Chapter 7 bankruptcy protection.

    Comment?

  6. Tengion Inc. Provides Clinical Update And Reports Third Quarter 2014...Read the original story

    Nov 17, 2014 | BioSpace

    Tengion, Inc. , a leader in regenerative medicine, today reported key clinical data along with financial and operating results for the quarter ended September 30, 2014. "We remain committed to realizing the full value of our Organ Regeneration Platform and to maximizing value for our stakeholders and, therefore, in September, we announced that we retained Jefferies LLC as an executive financial advisor to assist us with reviewing and structuring potential strategic transactions," commented John L. Miclot, President and Chief Executive Officer of Tengion.

    Comment?

  7. World could run seriously low on chocolate; Kevin Harvick claims...Read the original story w/Photo

    Nov 17, 2014 | Business Journal

    ... plan to ask the UNC Board of Governors to increase the school's tuition and fees, the News & Record reports . Tengion Inc., a Winston-Salem-based firm developing regenerative medicine technologies, says in a filing with the U.S. Securities and ...

    Comment?

  8. Tengion Inc. Provides Clinical Update And Reports Second Quarter 2014 Financial ResultsRead the original story

    Aug 13, 2014 | BioSpace

    Tengion, Inc. , a leader in regenerative medicine, today reported key clinical data along with financial and operating results for the quarter ended June 30, 2014.

    Comment?

  9. Tengion says regenerative kidney treatment trial on trackRead the original story w/Photo

    Aug 13, 2014 | Business Journal

    Tengion , the Winston-Salem biotech company working to commercialize some of the technologies developed by Dr. Anthony Atala and the Wake Forest Institute for Regenerative Medicine , said the Phase 1 clinical trial of its Neo-Kidney Augment is on track so far.

    Comment?

  10. Tengion Provides Clinical Update and Reports Second Quarter 2014 Financial ResultsRead the original story

    Aug 13, 2014 | GlobeNewswire

    Tengion, Inc. , a leader in regenerative medicine, today reported key clinical data along with financial and operating results for the quarter ended June 30, 2014.

    Comment?